The negative effects of obesity and poor glycemic control on cognitive function: A proposed model for possible mechanisms

Current Diabetes Reports

Volumn 14, Issue 6, 2014, Pages

  Alosco, Michael L ^a   Gunstad, John ^a  

^a KENT STATE UNIVERSITY   (United States)

Author keywords

Brain mechanisms; Cognitive function; Glycemic control; Obesity; Type 2 diabetes mellitus

Indexed keywords

AMYLOID BETA PROTEIN; BRAIN DERIVED NEUROTROPHIC FACTOR; GHRELIN; LEPTIN; GLUCOSE BLOOD LEVEL; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN;

ALZHEIMER DISEASE; ARTICLE; BRAIN FUNCTION; BRAIN PERFUSION; CEREBRAL HYPOPERFUSION; COGNITION; COGNITIVE DEFECT; GLYCEMIC CONTROL; HUMAN; IMPAIRED GLUCOSE TOLERANCE; LIFESTYLE MODIFICATION; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PATHOGENESIS; PHYSIOLOGICAL PROCESS; RISK FACTOR; WEIGHT REDUCTION; BLOOD; BRAIN; COMPLICATION; DEMENTIA; FEMALE; GLUCOSE BLOOD LEVEL; MALE; METABOLISM; MILD COGNITIVE IMPAIRMENT; PATHOLOGY; PSYCHOLOGY; RISK REDUCTION;

BLOOD GLUCOSE; BRAIN; COGNITION; DEMENTIA; DIABETES MELLITUS, TYPE 2; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MILD COGNITIVE IMPAIRMENT; OBESITY; RISK FACTORS; RISK REDUCTION BEHAVIOR;

EID: 84901581586     PISSN: 15344827     EISSN: 15390829     Source Type: Journal    
DOI: 10.1007/s11892-014-0495-z     Document Type: Article

References (102)

1. Go AS, Mozaffarian D, Roger VL, et al. Heart disease and stroke statistics - 2013 update: a report from the American Heart Association. Circulation. 2013;127:e6-e245.
2. Levi J, Segal LM, Laurent R, et al. F as in Fat: how obesity threatens Americas future. Trust for Americas Health. 2012.
3. Lenz M, Richter T, Muhlhauser I. The morbidity and mortality associated with overweight and obesity in adulthood. Dtsch Arztebl Int. 2009;106:641-8.
4. .•• Luchsinger JA. Midlife and late-life obesity and the risk of dementia: cardiovascular health study. Arch Neurol. 2009;66:336-42. This study shows that mid-life obesity is associated with increased risk for dementia.
5. Karlsson HK, Tuulari JJ, Hirvonen J, et al. Obesity is associated with white matter atrophy: a combined diffusion tensor imaging and voxel-based morphometric study. Obesity. 2013;21:2530-7.
6. Alosco ML, Spitznagel MB, Raz N, et al. Obesity interacts with cerebral hypoperfusion to exacerbate cognitive impairment in older adults with heart failure. Cerebrovasc Dis Extra. 2012;2:88-98.
7. .• Gunstad J, Strain G, Devlin MJ, et al. Improved memory function 12weeks after bariatric surgery. Surg Obes Relat Dis. 2011;7:465-72. The results from this study show that bariatric surgery patients exhibit significant cognitive impairments that improved 12-weeks postoperatively relative to obese controls.
8. .•• Benito-Leon J, Mitchell AJ, Hernandez-Gallego J, et al. Obesity and impaired cognitive functioning in the elderly: a population-based cross-sectional study (NEDICES). Eur J Neurol. 2013;20:899-906. This study documents the adverse effects of obesity on cognitive function in >1500 persons.
9. Mond JM, Stich H, Hay PJ. Associations between obesity and development functioning in pre-school children: a population-based study. Int J Obes. 2007;31:1068-73. (Pubitemid 46987778)
10. Lokken KL, Boeka AG, Austin AM, et al. Evidence of executive dysfunction in extremely obese adolescents: a pilot study. Surg Obes Relat Dis. 2009;5:547-52.
11. Fedor A, Gunstad J. Higher BMI is associated with reduced cognitive performance in division I athletes. Obes Facts. 2013;6: 185-92.
12. Gunstad J, Paul RH, Cohen RA, et al. Elevated bodymass index is associated with executive dysfunction in otherwise healthy adults. Compr Psychiatry. 2007;48:57-61. (Pubitemid 44826976)
13. Volkow ND, Wang GJ, Telang G, et al. Inverse association between BMI and prefrontal metabolic activity in healthy adults. Obesity. 2009;17:60-5. (Pubitemid 50310542)
14. Cournot M, Marqui JC, Ansiau D, et al. Relation between body mass index and cognitive function in healthy middle-aged men and women. Neurology. 2006;67:1208-14. (Pubitemid 44563829)
15. Gunstad J, Paul RH, Cohen RA, et al. Obesity is associated with memory deficits in young and middle-aged adults. Eat Weight Disor. 2006;11:e15-9. (Pubitemid 44073003)
16. Ott A, Stolk RP, van Harksamp F, et al. Diabetes mellitus and the risk of dementia. The Rotterdam Study. Neurology. 1999;53:1937.
17. Willeumier K, Taylor D, Amen D. Elevated BMI is associated with decreased blood flow in the prefrontal cortex using SPECT imaging in healthy adults. Obesity. 2011;19:1095-7.
18. Luchsinger JA, Cheng D, Tang MX, et al. Central obesity in the elderly is related to late-onset Alzheimer disease. Alzheimer Dis Assoc Disord. 2012;26:101-5.
19. Qiu C, Winblad B, Marengoni A, et al. Heart failure and risk of dementia and Alzheimer disease: a population-based cohort study. Arch Intern Med. 2006;166:1003-8.
20. Ruitenberg A, den Heijer T, Bakker SL, et al. Cerebral hypoperfusion and clinical onset of dementia: the Rotterdam Study. Ann Neurol. 2005;57:789-94. (Pubitemid 40798616)
21. Alosco ML, Brickman AM, Spitznagel MB, et al. Cerebral perfusion is associated with whitematter hyperintensities in older adults with heart failure. Congest Heart Fail. 2013;19:E29-34.
22. Mrak RE. Alzheimer-type neuropathological changes in morbidly obese individuals. Clin Neuropathol. 2009;28:40-5.
23. Ho AJ, Raji CA, Becker JT, et al. Obesity is linked with lower brain volume in 700 AD and MCI patients. Neurobiol Aging. 2010;31: 1326-39.
24. Yokum S,Ng J, Stice E. Relation of regional gray and white matter volumes to current BMI and future increases in BMI: a prospective MRI study. Int J Obes. 2012;36:656-64.
25. Gunstad J, Paul RH, Cohen RA, et al. Relationship between body mass index and brain volume in healthy adults. Int J Neurosci. 2008;118:1582-93.
26. Gustafson DR, Steen B, Skoog I. Body mass index and white matter lesions in elderly women. An 18-year longitudinal study. Int Psychogeriatr. 2004;16:327-36. (Pubitemid 39441496)
27. Jagust W, Harvey D, Mungas D, et al. Central obesity and the aging brain. Arch Neurol. 2005;62:1545-8. (Pubitemid 41434559)
28. Kurth F, Levitt JG, Phillips OR, et al. Relationships between gray matter, body mass index, and waist circumference in healthy adults. Hum Brain Mapp 2013;34:1737-46
29. Debette S, Markus HS. The clinical importance of white matter hyperintensities on brain magnetic resonance imaging: systematic review and meta-analysis. BMJ. 2010;341:c3666.
30. Stanek KM, Grieve SM, Brickman AM, et al. Obesity is associated with reduced white matter integrity in otherwise healthy adults. Obesity. 2011;19:500-4.
31. Boyle JP, Thompson TJ, Gregg EW, et al. Projection of the year 2050 burden of diabetes in the U.S. adult population: dynamic modeling of incidence, mortality, and prediabetes prevalence. Popul Health Metrics. 2010;8:29.
32. DeFronzo RA. Lilly lecture 1987. The triumvirate: beta-cell, muscle, liver. A collusion responsible for NIDDM [review]. Diabetes. 1988;37:667-87. (Pubitemid 19043172)
33. Shulman GI. Cellular mechanisms of insulin resistance. J Clin Invest. 2000;106:171-6. (Pubitemid 30483118)
34. Chan JM, Rimm EB, Colditz GA, et al. Obesity., fat distribution, and weight gain as risk factors for clinical diabetes in men. Diabetes Care. 1994;17:961-9. (Pubitemid 24268605)
35. Colditz GA, Willett WC, Stampfer MJ, et al. Weight as a risk factor for clinical diabetes in women. Am J Epidemiol. 1990;132:501-13. (Pubitemid 20285148)
36. Cowie CC, Rust KF, Ford ES, et al. Full accounting of diabetes and prediabetes in the U.S. population in 1988-1994 and 2005-2006. Diabetes Care. 2011;32:287-94.
37. Geiss LS, James C, Gregg EW, et al. Diabetes risk reduction behaviors among U.S. adults with prediabetes. Am J Prev Med. 2010;38:403-9.
38. Xu W, Caracciolo B, Wang HX, et al. Accelerated progression from mild cognitive impairment to dementia in people with diabetes. Diabetes. 2010;59:2928-35.
39. Awad N, Gagnon M, Messier C. The relationship between impaired glucose tolerance, type 2 diabetes, and cognitive function. J Clin Exp Neuropsychol. 2004;26:1044-80. (Pubitemid 39577337)
40. Yaffe K, Blackwell T, Kanaya AM, et al. Diabetes, impaired fasting glucose, and development of cognitive impairment in older women. Neurology. 2004;63:658-63. (Pubitemid 39100821)
41. Yau PL, Javier DC, Ryan CM, et al. Preliminary evidence for brain complications in obese adolescents with type 2 diabetes mellitus. Diabetologia. 2010;53:2298-306.
42. .• Luchsinger JA. Type 2 diabetes and cognitive impairment: linking mechanisms. J Alzheimers Dis. 2012;30:S185-98. This is a recent review paper highlighting the common mechanisms of cognitive impairment in type 2 diabetes mellitus.
43. Schmidt R, Launer LJ, Nilsson LG, et al. Magnetic resonance imaging of the brain in diabetes: the Cardiovascular Determinants of Dementia (CASCADE) Study. Diabetes. 2004;53:687-92. (Pubitemid 38270638)
44. Peila R, Rodriguez BL, Launer LJ. Type 2 diabetes, APOE gene, and the risk for dementia and related pathologies: the Honolulu- Asia Aging Study. Diabetes. 2002;51:1256-62. (Pubitemid 34438377)
45. Li ZG, Zhang W, Grunberger G, et al. Hippocampal neuronal apoptosis in type 1 diabetes. Brain Res. 2002;946:221-31. (Pubitemid 34876334)
46. Novak V, Last D, Alsop DC, et al. Cerebral blood flow velocity and periventricular white matter hyperintensities in type 2 diabetes. Diabetes Care. 2006;29:1529-34. (Pubitemid 44127576)
47. Xia W, Wang S, Sun Z, et al. Altered baseline brain activity in type 2 diabetes: a resting-state fMRI study. Psychoneuroendocrinology. 2013;38:2493-501.
48. Bruehl H, Sweat V, Tirsi A, Shah B, et al. Obese adolescents with type 2 diabetes mellitus have hippocampal and frontal lobe volume reductions. Neurosci Med. 2011;2:34-42.
49. Toda N. Age-related changes in endothelial function and blood flow regulation. Pharmacol Ther. 2012;133:159-76.
50. Whitmer RA, Gunderson EP, Quesenberry CP, et al. Body mass index in midlife and risk of Alzheimer disease and vascular dementia. Curr Alzheimer Res. 2007;4:103-9. (Pubitemid 46557496)
51. Park HS, Park JY, Yu R. Relationship of obesity and visceral adiposity with serum concentrations of CRP, TNF-alpha and IL-6. Diabetes Res Clin Prac. 2005;69:29-35. (Pubitemid 40813409)
52. Weaver JD, Huang MH, Albert M, et al. Interleukin-6 and risk of cognitive decline: MacArthur studies of successful aging. Neurology. 2002;59:371-8. (Pubitemid 34857929)
53. Yaffe K, Lindquist K, Penninx BW, et al. Inflammatory markers and cognition in well-functioning African-American and White elders. Neurology. 2003;61:76-80. (Pubitemid 36818750)
54. Vlassara H, Striker LJ, Teichberg S, et al. Advanced glycation end products induce glomerular sclerosis and albuminuria in normal rats. Proc Natl Acad Sci U S A. 1994;91:11704-8. (Pubitemid 24356413)
55. Stitt AW. Advanced glycation: an important pathological event in diabetic and age related ocular disease. Br J Ophthalmol. 2001;85: 746-53. (Pubitemid 32554256)
56. Brownlee M. Advanced protein glycosylation in diabetes and aging. Annu Rev Med. 1995;46:223-34.
57. Frolich L, Blum-Degen D, Bernstein HG, et al. Brain insulin and insulin receptors in aging and sporadic Alzheimer 's disease. J Neural Transm. 1998;105:423-38. (Pubitemid 28365027)
58. Small SA, Perera GM, DeLaPaz R, et al. Differential regional dysfunction of the hippocampal formation among elderly with memory decline and Alzheimer's disease. Ann Neurol. 1999;45:466-72. (Pubitemid 29165813)
59. Vanhanen M, Soininen H. Glucose intolerance, cognitive impairment and Alzheimer 's disease. Curr Opin Neurol. 1998;11: 673-7. (Pubitemid 28561204)
60. Craft S. Insulin resistance and Alzheimer 's disease pathogenesis: potential mechanisms and implications for treatment. Curr Alzheimer Res. 2007;4:147-52. (Pubitemid 46557503)
61. Wakisaka M, Nagamachi S, Inoue K, et al. Reduced regional cerebral blood flowin aged noninsulin-dependent diabetic patients with not history of cerebrovascular disease: evaluation by N-isopropyl-123I-p-iodoamphetamine with single-photon emission computed tomography. J Diabet Complicat. 1990;4:170-4.
62. Jakobsen J, Nedergaard M, Aarsle-jensen M, et al. Regional brain glucose metabolism and blood flow in streptozocin-induced diabetic rats. Diabetes. 1990;39:437-40. (Pubitemid 20111424)
63. Moll L, Schubert M. The role of insulin and insulin-like growth factor-1/FoxO-Mediated transcription for the pathogenesis of obesity-associated dementia. Curr Gerontol Geriatr Res. 2012;2012:384094.
64. Sagare A, Deane R, Bell RD, Johnson B, et al. Clearance of amyloid-beta by circulating lipoprotein receptors. Nat Med. 2007;13:1029-31. (Pubitemid 47517512)
65. Ravona-Springer R,Moshier E, et al. Changes in glycemic control are associated with changes in cognition in nondiabetic elderly. J Alzheimers Dis. 2012;30:299-309.
66. Yaffe K, Blackwell T,Whitmer RA, et al. Glycosated hemoglobin level and development of mild cognitive impairment or dementia in older women. J Nutr Health Aging. 2006;10:293-5.
67. Jorgensen L, Jenssen T, Joakimsen O, et al. Glycated hemoglobin level is strongly related to the prevalence of carotid artery plaques with high echogenicity in nondiabetic individuals: the Tromoso study. Circulation. 2004;110:466-70. (Pubitemid 38993858)
68. Duckrow RB, Beard DC, Brennan RW. Regional cerebral blood flow decreases during chronic and acute hyperglycemia. Stroke. 1987;18:52-8. (Pubitemid 17016685)
69. Enzinger C, Fazekas F, Matthews PM, et al. Risk factors for progression of brain atrophy in aging: 6 year follow-up of normal subjects. Neurology. 2005;64:1704-11. (Pubitemid 40695802)
70. Cameron AJ, Welborn TA, Zimmel PZ, et al. Overweight and obesity in Australia: the 1999-2000 Australian diabetes, obesity and lifestyle study (AusDiab). Med J Aust. 2003;178:427-32. (Pubitemid 36591915)
71. Luppino FS, de Wit LM, Bouvy PF, et al. Overweight, obesity, and depression: a systematic review and meta-analysis of longitudinal studies. Arch Gen Psychiatry. 2010;67:220-9.
72. Knopman D, Boland LL, Mosley T, et al. Cardiovascular risk factors and cognitive decline in middle-aged adults. Neurology. 2001;56:42-8. (Pubitemid 32059650)
73. Erickson KI, Weinstein AM, Lopez OL. Physical activity, brain plasticity, and Alzheimer's disease. Arch Med Res. 2012;43:615-21.
74. Alosco ML, Spitznagel MB, Raz N, et al. The interactive effects of cerebral perfusion and depression on cognitive function in older adults with heart failure. Psychosom Med. 2013;75:632-9.
75. Wolf PA, Beiser A, Elias MF, et al. Relation of obesity to cognitive function: importance of central obesity and synergistic influence of concomitant hypertension. The Framingham Heart Study. Curr Alzheimer Res. 2007;4:111-6. (Pubitemid 46557497)
76. Marks BL, Katz LM, Styner M, et al. Aerobic fitness and obesity: relationship to cerebral white matter integrity in the brain of active and sedentary older adults. Br J Sport Med. 2011;45:1208-15.
77. Peng S, Zhu Y, Xu F, et al. FTO gene polymorphisms and obesity risk: a meta-analysis. BMC Med. 2011;9:71.
78. Ho AJ, Stein JL, Hua X, et al. A commonly carried allele of the obesity-related gene is associated with reduced brain volume in the healthy elderly. Proc Natl Acad Sci U S A. 2010;107:8404-9.
79. Mielke MM, Leoutsakos JM, Tschanz JT, et al. Interaction between vascular factors and the APOE ε4 allele in predicting rate of progression in Alzheimer's disease. J Alzheimer Dis. 2011;26: 127-34.
80. Wren AM, Seal LJ, Cohen MA, et al. Ghrelin enhances appetite and increases food intake in humans. J Clin Endocrinol Metab. 2001;86:5992-5. (Pubitemid 33152655)
81. Xu B, Goulding EH, Zang K, et al. Brain-derived neurotrophic factor regulates energy balance downstream of menacortin-4 receptor. Nat Neurosci. 2003;6:736-42. (Pubitemid 36792889)
82. Sorensen T, Echwald SM, Holm J. Leptin in obesity. BMJ. 1996;313:953-4. (Pubitemid 26385516)
83. Lee Y, Martin JM, Maple RL, et al. Plasma Amyloid-beta peptide levels correlate with adipocyte amyloid precursor protein gene expression in obese individuals. Neuroendocrinology. 2009;90:383-90.
84. Gunstad J, Bausserman L, Paul RH, et al. C-reactive protein, but not homocysteine, is related to cognitive dysfunction in older adults with cardiovascular disease. J Clin Neurosci. 2006;13: 540-6. (Pubitemid 43850280)
85. Finch CE, Morgan TE. Systemic inflammation, infection, ApoE alleles, and Alzheimer disease: a position Paper. Curr Alzheimer Res. 2007;4:185-9. (Pubitemid 46562393)
86. Lee EB. Obesity, leptin, and Alzheimer's disease. Ann N YAcad Sci. 2011;1243:15-29.
87. Diano S, Farr SA, Benoit SC, et al. Ghrelin controls hippocampal spine synapse density and memory performance. Nat Neurosci. 2006;9:381-8. (Pubitemid 43290968)
88. Diniz BS, Teizeira AL. Brain-derived neurotrophic factor and Alzheimer 's disease: physiopathology and beyond. Neuromol Med. 2011;13:217-22.
89. Gunstad J, Spitznagel M, Keary T, et al. Serum leptin levels are associated with cognitive function in older adults. Brain Res. 2008;1230:233-6.
90. Ghanim H, Monte SV, Sia CL, et al. Reduction in inflammation and the expression of amyloid precursor protein and other proteins related to Alzheimer's disease following gastric bypass surgery. J Clin Endocrinol Metab. 2012;97:E1197-201.
91. Strohacker K, McCaffery JM, Maclean PS, et al. Adaptation of leptin, ghrelin or insulin during weight loss as predictors weight regain: a review of current literature. Int J Obes (London) 2014;38: 388-96.
92. Ades PA, Savage PD. Potential benefits of weight loss in coronary heart disease. Prog Cardiovasc Dis. 2014;56:448-56.
93. Terra X, Auguet T, Guiu-Jurado E, et al. Long-term changes in leptin, chemerin, and Ghrelin levels following different bariatric surgery procedures: Roux-en-Y Gastric bypass and sleeve gastrectomy. Obes Surg. 2013;23:1790-8.
94. Luchsinger JA, Palmas W, Teresi JA, et al. Improved diabetes control in the elderly delays global cognitive decline. J Nutr Health Aging. 2011;15:445-9.
95. Launer LJ, Miller ME, Williamson JD, et al. Effects of intensive glucose lowering on brain structure and function in people with type 2 diabetes (ACCORD MIND): a randomized open-label substudy. Lancet Neurol. 2011;10:969-77.
96. Shaik MM, Hua GS, Kamal MA. Epigenomic approach in understanding Alzheimer's disease and type 2 diabetes mellitus. CNS Neurol Disord Drug Targets. 2014;13(2):283-9.
97. Stilley CS, Bender CM, Dunbar-Jacob J, et al. The impact of cognitive function on medication management: three studies. Health Psychol. 2010;29:50-5.
98. Alosco ML, Spitznagel MB, van Dulmen M, et al. Cognitive function and treatment adherence in older adults with heart failure. Psychosom Med. 2012;74:965-73.
99. Spitznagel MB, Galioto R, Limbach K, et al. Cognitive function is linked to adherence to bariatric postoperative guidelines. Surg Obes Relat Dis. 2013;9:580-5.
100. Alosco ML, Spitznagel MB, Strain G, et al. Improved memory function two years after bariatric surgery. Obesity (Silver Spring). 2014;22:32-8.
101. .•• Brethauer SA, Aminian A, Romera-Talamas H, et al. Can diabetes be surgically cured? Long-term metabolic effects of bariatric surgery in obese patients with type 2 diabetes mellitus. Ann Surg. 2013;258:628-37. Bariatric surgery with sustainable remission and improvement in T2DM.
102. Siervo M, Nasti G, Stephan BC, et al. Effects of intentional weight loss on physical and cognitive function in middleaged and older obese participants: a pilot study. J Am Coll Nutr. 2012;31:79 - 86.